This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Brown, P. D. Articles by Stetler-Stevenson, W. G. Search for Related Content PubMed PubMed Citation Articles by Brown, P. D. Articles by Stetler-Stevenson, W. G.

Independent Expression and Cellular Processing of M_r 72,000 Type IV Collagenase and Interstitial Collagenase in Human Tumorigenic Cell Lines

Laboratory of Pathology, National Cancer Institute, NIH, Bethesda, Maryland 20892

The regulation of M_r 72,000 type IV collagenase and interstitial collagenase expression was studied in vitro. Three tumorigenic human cell lines were used, together with human fetal lung fibroblasts as a nontumorigenic control. M_r 72,000 type IV collagenase was expressed constitutively by all four cell lines, whereas only A2058 melanoma cells exhibited constitutive expression of interstitial collagenase. Treatment of cells with transforming growth factor ß1 (TGF-ß1) and 12-O-tetradecanoylphorbol-13-acetate (TPA) revealed an opposite pattern of regulation of these two metalloproteinases. Specifically, TPA increased interstitial collagenase mRNA levels in each cell line and decreased type IV collagenase mRNA levels in control fibroblasts and the tumorigenic cell lines, HT-1080 and A2058. TGF-ß1 treatment increased type IV collagenase mRNA levels in each cell line and decreased interstitial collagenase mRNA levels in A2058 melanoma cells.

Interstitial collagenase mRNA induction was accompanied in all cell lines by elevated interstitial procollagenase in the conditioned medium, as detected by zymography. Changes in M_r 72,000 type IV collagenase expression revealed a more complex pattern of regulation. TPA and TGF-ß1 treatment of HT-1080 cells resulted in the appearance of two bands of gelatinolytic activity with a molecular weight of approximately 62,000 and 59,000. The M_r 62,000 species was also induced by TGF-ß1 treatment of A2058 cells. Addition of affinity-purified radiolabeled M_r 72,000 type IV procollagenase to TPA-treated HT-1080 cells demonstrated that both species were products of the M_r 72,000 proenzyme and that exogenous proenzyme could be processed by these cells. Western blot analysis with specific antipeptide antibodies revealed that both the M_r 62,000 and 59,000 species were derived from the M_r 72,000 proenzyme by amino-terminal cleavage. There was no evidence for cellular processing of either interstitial procollagenase or the M_r 92,000 type IV procollagenase. These results demonstrate that the M_r 72,000 type IV collagenase is under the control of different regulatory elements from interstitial collagenase, at the level of both mRNA expression and cellular processing, and that this processing appears to be the result of a phorbol ester and TGF-ß1-inducible cellular activation mechanism. The ratio of active enzyme species to latent M_r 72,000 proenzyme may provide a better correlation with invasive potential than overall levels of this widely expressed metalloproteinase.

¹ To whom requests for reprints should be addressed, at Laboratory of Pathology, Bldg. 10, Rm. 2A33, National Cancer Institute, NIH, Bethesda, MD 20892.

Received 3/23/90. Accepted 6/28/90.

This article has been cited by other articles:

				P. O-charoenrat, I. Sarkaria, S. G. Talbot, P. Reddy, S. Dao, I. Ngai, A. Shaha, D. Kraus, J. Shah, V. Rusch, et al. SCCRO (DCUN1D1) Induces Extracellular Matrix Invasion by Activating Matrix Metalloproteinase 2 Clin. Cancer Res., November 1, 2008; 14(21): 6780 - 6789. [Abstract] [Full Text] [PDF]

				S. Simsa, A. Hasdai, H. Dan, and E. M. Ornan Differential regulation of MMPs and matrix assembly in chicken and turkey growth-plate chondrocytes Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2007; 292(6): R2216 - R2224. [Abstract] [Full Text] [PDF]

				Y. Sawada, K. Onoda, K. Imanaka-Yoshida, J. Maruyama, K. Yamamoto, T. Yoshida, and H. Shimpo Tenascin-C synthesized in both donor grafts and recipients accelerates artery graft stenosis Cardiovasc Res, June 1, 2007; 74(3): 366 - 376. [Abstract] [Full Text] [PDF]

				H. Song, S. H. Ki, S. G. Kim, and A. Moon Activating Transcription Factor 2 Mediates Matrix Metalloproteinase-2 Transcriptional Activation Induced by p38 in Breast Epithelial Cells Cancer Res., November 1, 2006; 66(21): 10487 - 10496. [Abstract] [Full Text] [PDF]

				G. Ge and D. S. Greenspan BMP1 controls TGF{beta}1 activation via cleavage of latent TGF{beta}-binding protein J. Cell Biol., October 9, 2006; 175(1): 111 - 120. [Abstract] [Full Text] [PDF]

				J. Choi, K. Choi, E. N. Benveniste, Y.-S. Hong, J.-H. Lee, J. Kim, and K. Park Bcl-2 Promotes Invasion and Lung Metastasis by Inducing Matrix Metalloproteinase-2 Cancer Res., July 1, 2005; 65(13): 5554 - 5560. [Abstract] [Full Text] [PDF]

				C. H. Stuelten, S. D. Byfield, P. R. Arany, T. S. Karpova, W. G. Stetler-Stevenson, and A. B. Roberts Breast cancer cells induce stromal fibroblasts to express MMP-9 via secretion of TNF-{alpha} and TGF-{beta} J. Cell Sci., May 15, 2005; 118(10): 2143 - 2153. [Abstract] [Full Text] [PDF]

				M. J. Wilson, A. Jiang, C. Wiehr, X. Wang, A. A. Sinha, and D. Pei Limited Processing of Pro-Matrix Metalloprotease-2 (Gelatinase A) Overexpressed by Transfection in PC-3 Human Prostate Tumor Cells: Association With Restricted Cell Surface Localization of Membrane-Type Matrix Metalloproteinase-1 J Androl, March 1, 2004; 25(2): 274 - 285. [Abstract] [Full Text] [PDF]

				X. Liao, J. B. Thrasher, J. Pelling, J. Holzbeierlein, Q.-X. A. Sang, and B. Li Androgen Stimulates Matrix Metalloproteinase-2 Expression in Human Prostate Cancer Endocrinology, May 1, 2003; 144(5): 1656 - 1663. [Abstract] [Full Text] [PDF]

				S. Aznavoorian, B. A. Moore, L. D. Alexander-Lister, S. L. Hallit, L. J. Windsor, and J. A. Engler Membrane Type I-Matrix Metalloproteinase-Mediated Degradation of Type I Collagen by Oral Squamous Cell Carcinoma Cells Cancer Res., August 1, 2001; 61(16): 6264 - 6275. [Abstract] [Full Text] [PDF]

				M. A. Behzadian, X.-L. Wang, L. J. Windsor, N. Ghaly, and R. B. Caldwell TGF-{beta} Increases Retinal Endothelial Cell Permeability by Increasing MMP-9: Possible Role of Glial Cells in Endothelial Barrier Function Invest. Ophthalmol. Vis. Sci., March 1, 2001; 42(3): 853 - 859. [Abstract] [Full Text]

				B. Steffensen, L. Hakkinen, and H. Larjava Proteolytic Events of Wound-Healing -- Coordinated Interactions Among Matrix Metalloproteinases (MMPs), Integrins, and Extracellular Matrix Molecules Critical Reviews in Oral Biology & Medicine, January 1, 2001; 12(5): 373 - 398. [Abstract] [Full Text] [PDF]

				M. W. Olson, M. M. Bernardo, M. Pietila, D. C. Gervasi, M. Toth, L. P. Kotra, I. Massova, S. Mobashery, and R. Fridman Characterization of the Monomeric and Dimeric Forms of Latent and Active Matrix Metalloproteinase-9. DIFFERENTIAL RATES FOR ACTIVATION BY STROMELYSIN 1 J. Biol. Chem., January 28, 2000; 275(4): 2661 - 2668. [Abstract] [Full Text] [PDF]

				J. A. Rada, C. A. Perry, M. L. Slover, and V. R. Achen Gelatinase A and TIMP-2 Expression in the Fibrous Sclera of Myopic and Recovering Chick Eyes Invest. Ophthalmol. Vis. Sci., December 1, 1999; 40(13): 3091 - 3099. [Abstract] [Full Text] [PDF]

				Y. S. Kanwar, K. Ota, Q. Yang, J. Wada, N. Kashihara, Y. Tian, and E. I. Wallner Role of membrane-type matrix metalloproteinase 1 (MT-1-MMP), MMP-2, and its inhibitor in nephrogenesis Am J Physiol Renal Physiol, December 1, 1999; 277(6): F934 - F947. [Abstract] [Full Text] [PDF]

				B. C. Kieseier, R. Paul, U. Koedel, T. Seifert, J. M. Clements, A. J. H. Gearing, H.-W. Pfister, and H.-P. Hartung Differential expression of matrix metalloproteinases in bacterial meningitis Brain, August 1, 1999; 122(8): 1579 - 1587. [Abstract] [Full Text] [PDF]

				N. Ramos-DeSimone, E. Hahn-Dantona, J. Sipley, H. Nagase, D. L. French, and J. P. Quigley Activation of Matrix Metalloproteinase-9 (MMP-9) via a Converging Plasmin/Stromelysin-1 Cascade Enhances Tumor Cell Invasion J. Biol. Chem., May 7, 1999; 274(19): 13066 - 13076. [Abstract] [Full Text] [PDF]

				S. Higashi and K. Miyazaki Reactive Site-modified Tissue Inhibitor of Metalloproteinases-2 Inhibits the Cell-mediated Activation of Progelatinase A J. Biol. Chem., April 9, 1999; 274(15): 10497 - 10504. [Abstract] [Full Text] [PDF]

				X.-P. Xu, S. R. Meisel, J. M. Ong, S. Kaul, B. Cercek, T. B. Rajavashisth, B. Sharifi, and P. K. Shah Oxidized Low-Density Lipoprotein Regulates Matrix Metalloproteinase-9 and Its Tissue Inhibitor in Human Monocyte-Derived Macrophages Circulation, March 2, 1999; 99(8): 993 - 998. [Abstract] [Full Text] [PDF]

				I. Sehgal and T. C. Thompson Novel Regulation of Type IV Collagenase (Matrix Metalloproteinase-9 and -2) Activities by Transforming Growth Factor-beta 1 in Human Prostate Cancer Cell Lines Mol. Biol. Cell, February 1, 1999; 10(2): 407 - 416. [Abstract] [Full Text]

				Y. Itoh, A. Ito, K. Iwata, K. Tanzawa, Y. Mori, and H. Nagase Plasma Membrane-bound Tissue Inhibitor of Metalloproteinases (TIMP)-2 Specifically Inhibits Matrix Metalloproteinase 2 (Gelatinase A) Activated on the Cell Surface J. Biol. Chem., September 18, 1998; 273(38): 24360 - 24367. [Abstract] [Full Text] [PDF]

				B. Steffensen, H. F. Bigg, and C. M. Overall The Involvement of the Fibronectin Type II-like Modules of Human Gelatinase A in Cell Surface Localization and Activation J. Biol. Chem., August 7, 1998; 273(32): 20622 - 20628. [Abstract] [Full Text] [PDF]

				T. Kinoshita, H. Sato, A. Okada, E. Ohuchi, K. Imai, Y. Okada, and M. Seiki TIMP-2 Promotes Activation of Progelatinase A by Membrane-type 1 Matrix Metalloproteinase Immobilized on Agarose Beads J. Biol. Chem., June 26, 1998; 273(26): 16098 - 16103. [Abstract] [Full Text] [PDF]

				H. Hebestreit, B. Dibbert, I. Balatti, D. Braun, A. Schapowal, K. Blaser, and H.-U. Simon Disruption of Fas Receptor Signaling by Nitric Oxide in Eosinophils J. Exp. Med., February 2, 1998; 187(3): 415 - 425. [Abstract] [Full Text] [PDF]

				A Karameris, P Panagou, T Tsilalis, and D Bouros Association of expression of metalloproteinases and their inhibitors with the metastatic potential of squamous-cell lung carcinomas. A molecular and immunohistochemical study Am. J. Respir. Crit. Care Med., December 1, 1997; 156(6): 1930 - 1936. [Abstract] [Full Text]

				M. W. Olson, D. C. Gervasi, S. Mobashery, and R. Fridman Kinetic Analysis of the Binding of Human Matrix Metalloproteinase-2 and -9 to Tissue Inhibitor of Metalloproteinase (TIMP)-1 and TIMP-2 J. Biol. Chem., November 21, 1997; 272(47): 29975 - 29983. [Abstract] [Full Text] [PDF]

				R. D. Kenagy, C. E. Hart, W. G. Stetler-Stevenson, and A. W. Clowes Primate Smooth Muscle Cell Migration From Aortic Explants Is Mediated by Endogenous Platelet-Derived Growth Factor and Basic Fibroblast Growth Factor Acting Through Matrix Metalloproteinases 2 and 9 Circulation, November 18, 1997; 96(10): 3555 - 3560. [Abstract] [Full Text]

				E. Duhamel-Clerin, C. Orvain, F. Lanza, J.-P. Cazenave, and C. Klein-Soyer Thrombin Receptor-Mediated Increase of Two Matrix Metalloproteinases, MMP-1 and MMP-3, in Human Endothelial Cells Arterioscler Thromb Vasc Biol, October 1, 1997; 17(10): 1931 - 1938. [Abstract] [Full Text]

				T. Sorsa, T. Salo, E. Koivunen, J. Tyynela, Y. T. Konttinen, U. Bergmann, A. Tuuttila, E. Niemi, O. Teronen, P. Heikkila, et al. Activation of Type IV Procollagenases by Human Tumor-associated Trypsin-2 J. Biol. Chem., August 22, 1997; 272(34): 21067 - 21074. [Abstract] [Full Text] [PDF]

				A. Ginestra, S. Monea, G. Seghezzi, V. Dolo, H. Nagase, P. Mignatti, and M. L. Vittorelli Urokinase Plasminogen Activator and Gelatinases Are Associated with Membrane Vesicles Shed by Human HT1080 Fibrosarcoma Cells J. Biol. Chem., July 4, 1997; 272(27): 17216 - 17222. [Abstract] [Full Text] [PDF]

				C.-Y. Lin, J.-K. Wang, J. Torri, L. Dou, Q. A. Sang, and R. B. Dickson Characterization of a Novel, Membrane-bound, 80-kDa Matrix-degrading Protease from Human Breast Cancer Cells. MONOCLONAL ANTIBODY PRODUCTION, ISOLATION, AND LOCALIZATION J. Biol. Chem., April 4, 1997; 272(14): 9147 - 9152. [Abstract] [Full Text] [PDF]

				R.D. Kenagy, S. Vergel, E. Mattsson, M. Bendeck, M.A. Reidy, and A.W. Clowes The Role of Plasminogen, Plasminogen Activators, and Matrix Metalloproteinases in Primate Arterial Smooth Muscle Cell Migration Arterioscler Thromb Vasc Biol, November 1, 1996; 16(11): 1373 - 1382. [Abstract] [Full Text]

				H. Y. Lee, T. Clair, P. T. Mulvaney, E. C. Woodhouse, S. Aznavoorian, L. A. Liotta, and M. L. Stracke Stimulation of Tumor Cell Motility Linked to Phosphodiesterase Catalytic Site of Autotaxin J. Biol. Chem., October 4, 1996; 271(40): 24408 - 24412. [Abstract] [Full Text] [PDF]

				H. Schnaper, J. Kopp, A. Poncelet, S. Hubchak, W. Stetler-Stevenson, P. Klotman, and H. Kleinman Increased expression of extracellular matrix proteins and decreased expression of matrix proteases after serial passage of glomerular mesangial cells J. Cell Sci., January 10, 1996; 109(10): 2521 - 2528. [Abstract] [PDF]

				H Kinoh, H Sato, Y Tsunezuka, T Takino, A Kawashima, Y Okada, and M Seiki MT-MMP, the cell surface activator of proMMP-2 (pro-gelatinase A), is expressed with its substrate in mouse tissue during embryogenesis J. Cell Sci., January 5, 1996; 109(5): 953 - 959. [Abstract] [PDF]

				T. Takino, H. Sato, A. Shinagawa, and M. Seiki Identification of the Second Membrane-type Matrix Metalloproteinase (MT-MMP-2) Gene from a Human Placenta cDNA Library J. Biol. Chem., September 29, 1995; 270(39): 23013 - 23020. [Abstract] [Full Text] [PDF]

				Y. Ogata, Y. Itoh, and H. Nagase Steps Involved in Activation of the Pro-matrix Metalloproteinase 9 (Progelatinase B)-Tissue Inhibitor of Metalloproteinases-1 Complex by 4-Aminophenylmercuric Acetate and Proteinases J. Biol. Chem., August 4, 1995; 270(31): 18506 - 18511. [Abstract] [Full Text] [PDF]

				J. Lohi and J. Keski-Oja Calcium Ionophores Decrease Pericellular Gelatinolytic Activity via Inhibition of 92-kDa Gelatinase Expression and Decrease of 72-kDa Gelatinase Activation J. Biol. Chem., July 21, 1995; 270(29): 17602 - 17609. [Abstract] [Full Text] [PDF]

				R. T. Aimes and J. P. Quigley Matrix Metalloproteinase-2 Is an Interstitial Collagenase J. Biol. Chem., March 17, 1995; 270(11): 5872 - 5876. [Abstract] [Full Text] [PDF]

				J. Cao, H. Sato, T. Takino, and M. Seiki The C-terminal Region of Membrane Type Matrix Metalloproteinase Is a Functional Transmembrane Domain Required for Pro-gelatinase A Activation J. Biol. Chem., January 13, 1995; 270(2): 801 - 805. [Abstract] [Full Text] [PDF]

				U. T. Shankavaram, W.-C. Lai, S. Netzel-Arnett, P. R. Mangan, J. A. Ardans, N. Caterina, W. G. Stetler-Stevenson, H. Birkedal-Hansen, and L. M. Wahl Monocyte Membrane Type 1-Matrix Metalloproteinase. PROSTAGLANDIN-DEPENDENT REGULATION AND ROLE IN METALLOPROTEINASE-2 ACTIVATION J. Biol. Chem., May 25, 2001; 276(22): 19027 - 19032. [Abstract] [Full Text] [PDF]

				E. Piek, W. J. Ju, J. Heyer, D. Escalante-Alcalde, C. L. Stewart, M. Weinstein, C. Deng, R. Kucherlapati, E. P. Bottinger, and A. B. Roberts Functional Characterization of Transforming Growth Factor beta Signaling in Smad2- and Smad3-deficient Fibroblasts J. Biol. Chem., June 1, 2001; 276(23): 19945 - 19953. [Abstract] [Full Text] [PDF]

				C. Bremer, S. Bredow, U. Mahmood, R. Weissleder, and C.-H. Tung Optical Imaging of Matrix Metalloproteinase-2 Activity in Tumors: Feasibility Study in a Mouse Model Radiology, November 1, 2001; 221(2): 523 - 529. [Abstract] [Full Text] [PDF]